E Fund Management (HK)’s Burning Rock Biotech BNR Stock Holding History

E Fund Management (HK)’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.13M	Buy	10,613 +1,113	+12%	+$329K	1.95%	18
2021 Q1	$2.56M	Buy	+9,500	New	+$2.89M	0.82%	19

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

E Fund Management (HK)'s BNR Position: Q2 2021 in Review

E Fund Management (HK) increased its Burning Rock Biotech (BNR) stake by 12% in Q2 2021, buying an estimated $329K and bringing the position to 10,613 shares worth $3.13M. The position accounts for 1.95% of the portfolio, ranked #18.

E Fund Management (HK) first reported a position in BNR in Q1 2021 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold BNR as of Q2 2021.

E Fund Management (HK) held 10,613 shares of Burning Rock Biotech worth $3.13M as of Q2 2021.
E Fund Management (HK) bought 1,113 Burning Rock Biotech shares in Q2 2021, an estimated $329K.
Burning Rock Biotech made up 1.95% of E Fund Management (HK)'s portfolio in Q2 2021, its #18 holding.
E Fund Management (HK) first reported a position in Burning Rock Biotech in Q1 2021 and has held it in 2 quarters since.
85 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2021.

Based on E Fund Management (HK)'s 13F filing for Q2 2021, filed 27 Jul 2021.